News
UnitedHealth beat Q2 profit and revenue estimates and raised full-year guidance, but rising commercial insurance costs and a federal probe keep the recovery story in question.
News
UnitedHealth shares surged over 3.5% in after-hours trading after Baird upgraded the stock to Outperform and the company delivered a massive Q2 earnings beat, raising its full-year guidance.
News
UnitedHealth Group executives warned on the Q2 earnings call that the No Surprises Act’s independent dispute resolution process is being “exploited” by certain providers, dragging on commercial business. The company also faces a sharp drop in ACA and Medicaid enrollment and an 11% surge…
News
UnitedHealth Group smashed Q2 estimates as its medical cost ratio dropped to 86.7%, driving net income to $5.48 billion. The company lifted its full-year EPS guidance to $19.50–$20.00, well above its prior “above $17.75” outlook.
News
The DOJ’s antitrust probe into healthcare data firm Claritev has intensified, sending UnitedHealth Group — a key customer and shareholder — down nearly 1% after hours. The stock hit a fresh intraday low as regulatory scrutiny of the healthcare sector broadens.